Stuart Olson Inc. (SOX) Analysts See $0.05 EPS

Stuart Olson Inc. (TSE:SOX) Logo

Analysts expect Stuart Olson Inc. (TSE:SOX) to report $0.05 EPS on November, 5.They anticipate $0.07 EPS change or 58.33 % from last quarter’s $0.12 EPS. T_SOX’s profit would be $1.41M giving it 13.60 P/E if the $0.05 EPS is correct. After having $-0.08 EPS previously, Stuart Olson Inc.’s analysts see -162.50 % EPS growth. The stock decreased 3.55% or $0.1 during the last trading session, reaching $2.72. About 15,082 shares traded. Stuart Olson Inc. (TSE:SOX) has 0.00% since October 7, 2018 and is . It has by 0.00% the S&P500.

Stuart Olson Inc. provides general contracting and electrical building systems contracting to the institutional and commercial construction markets in Canada. The company has market cap of $76.94 million. The Buildings Group provides integrated project delivery, construction management, and design-build construction services. It currently has negative earnings. The Commercial Systems Group engages in designing, building, maintaining, and servicing electrical and life safety systems, security infrastructure, and other related building technology systems, as well as voice, data, and communications networks for commercial, institutional, and multi-tenant residential buildings.

More notable recent Stuart Olson Inc. (TSE:SOX) news were published by: which released: “BU ends 38-year drought in Women’s Beanpot – The Boston Globe” on February 13, 2019, also with their article: “Renesas Electronics Introduces Family of 15 Mbps Photocouplers With Industry Leading Features for Harsh Industrial Applications – Business Wire” published on July 23, 2019, published: “Trinseo Named Ryan Leib, Bernard Skeete, and Lori Wilcox to New Roles on its Financial Leadership Team – Business Wire” on May 07, 2019. More interesting news about Stuart Olson Inc. (TSE:SOX) were released by: and their article: “2018-19 Boys’ Volleyball All-Scholastics – The Boston Globe” published on August 03, 2019 as well as‘s news article titled: “BridgeBio Pharma’s Origin Biosciences Presents New Data on the Natural History of Molybdenum Cofactor Deficiency (MoCD) Type A at the Society of the Study of Inborn Errors of Metabolism (SSIEM) Conference – Yahoo Finance” with publication date: September 05, 2019.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.